Skip to main content

Table 1 Reported cases of Aerococcus urinae endocarditis

From: A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature

Case No. Age (yrs) Sex Risk Factors Valve Surgery (y/n) Antibiotic Regimen Duration Survived(y/n) Ref No.
1 69 M Cystoscopy Av N β Lactam/AG 6wks Y [13]
2 54 M Phimosis Mv Y β Lactam 6wks Y [32]
3 43 M Hepatitis C Av N β Lactam/AG 5 days N [19]
4 68 M Indwelling Catheter Av Y β Lactam/AG 6/2wks Y [29]
5 80 M Malignancy Av Y β Lactam 6wks Y [33]
6 77 M BPH Av N β Lactam/Van N [10]
7 68 M BPH Mv N β Lactam/AG;
oral regimen
3wks; unknown Y [14]
8 75 M Cystoscopy Av Y β Lactam/AG 6wks Y [15]
9 89 M TURP Mv N β Lactam/AG 7 days N [16]
10 81 M UTI Av N β Lactam/AG 2wks/8da N [34]
11 42 M None Av Y β Lactam/AG 6wks Y [18]
12 49 M Av β Lactam/AG Y [35]
13 54 M Urethral Stricture T/Av N β Lactam/AG N [36]
14 69 M Malignancy Av Y β Lactam 12wks Y [17]
15 62 M BPH M/Av Y β Lactam/Rif, AG 6wks, AG 2wks Y [25]
16 78 M Aortic stenosis Av N β Lactam/AG 10 days N [26]
17 74 M BPH Mv Y β Lactam/AG 4wks N [11]
18 81 M BPH Mv N β Lactam/AG 6wks Y [12]
19 78 M Indwelling Catheter Av N β Lactam N [12]
20 87 M BPH Mv N N [12]
21 78 F Ureteral Stent Av N β Lactam/Van 2wks N [12]
22 48 M ASD Mv N β Lactam/AG Y [27]
23 79 F UTI Av N β Lactam 6wks Y [27]
24 91 M Indwelling Catheter Mv β Lactam/AG 4wks/10db Y [5]
25 91 M BPH Mv β Lactam/AG 4wks/10db Y [5]
26 89 F Mv β Lactam/AG 4wks/10db Y [5]
27 86 M Urethral Stricture Av β Lactam/AG 4wks/10db Y [5]
28 83 M Urethral Stricture Mv β Lactam/AG 4wks/10db Y [5]
29 80 F Mv β Lactam/AG 4wks/10db Y [5]
30 77 M Av β Lactam/AG 4wks/10db Y [5]
31 75 M BPH Mv β Lactam/AG 4wks/10db Y [5]
32 74 M Suprapubic Catheter β Lactam/AG 4wks/10db Y [5]
33 65 M Indwelling Catheter Mv β Lactam/AG 4wks/10db Y [5]
34 53 M Dysuria Av β Lactam/AG 4wks/10db Y [5]
35 49 F Intermittent Catheter Av β Lactam/AG 4wks/10db Y [5]
36 81 M Indwelling Catheter Mv β Lactam/AG 4wks/10db Y [5]
37 74 F Malignancy β Lactam/AG 4wks/10db Y [5]
38 87 M Malignancy Mv β Lactam/AG N [9]
39 77 M Liver Failure Av β Lactam/AG Y [9]
40 83 M Indwelling Catheter Mv β Lactam/AG Y [9]
41 73 M Suprapubic Catheter β Lactam/AG N [9]
42 88 F Aortic Stenosis Av β Lactam/AG Y [9]
43 43 M Indwelling Catheter Mv Y β Lactam/AG 6wks Y a
  1. β Lactam/AG Beta-Lactam/Aminoglycoside, Van-vancomycin, BPH benign prostatic hyperplasia; ASD Atrial septal defect, TURP trans-urethral prostate biopsy, UTI urinary tract infection, aThis paper, bMedian Duration of therapy for each agent